What is ANEB stock price today?

ANEB (Anebulo Pharmaceuticals Inc) stock is trading at $0.55 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ANEB stock going up or down today?

ANEB stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ANEB stock now?

The decision to buy ANEB depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ANEB a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ANEB based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ANEB stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ANEB is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ANEB's P/E ratio?

P/E ratio data for ANEB will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ANEB's market cap?

ANEB (Anebulo Pharmaceuticals Inc) has a market capitalization of $0.02 billion, making it a small-cap stock.

What is ANEB's price to book ratio?

ANEB trades at a price-to-book (P/B) ratio of 2.82, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ANEB pay dividends?

ANEB does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ANEB's dividend yield?

ANEB does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ANEB stock a good long-term investment?

ANEB's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ANEB's revenue growth rate?

Revenue growth data for ANEB is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ANEB are available on our dashboard with complete income statement analysis.

What are the risks of investing in ANEB?

Key risks for ANEB include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ANEB compare to its competitors?

Compare ANEB to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ANEB's performance and positioning.

What is ANEB's stock price target for 2026?

Our AI model provides price targets for ANEB based on fundamental analysis: Bull case $0.72 (+30%), Base case $0.63 (+15%), Bear case $0.50 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ANEB?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ANEB. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ANEB's next earnings report?

ANEB reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ANEB - Anebulo Pharmaceuticals Inc

NYSE * Health Care * Biotechnology

$0.55

+$0.11 (+25.00%)

About Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.

ANEB Key Statistics

Market Cap

$22.43M

P/B Ratio

2.82

EPS

$-0.18

Employees

How ANEB Compares to Peers

ANEB is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ANEB(This stock)	$22.43M	N/A	0%	0.0%	-
AMGNAmgen Inc	$197.41B	25.7	0%	0.2%	vs AMGN
GILDGilead Sciences	$179.99B	21.4	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$119.21B	30.7	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$78.84B	18.0	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.64B	20.7	-0%	0.1%	vs BIIB

Anebulo Pharmaceuticals Inc Company Information

Headquarters: Texas; U.S.A
Website: www.anebulo.com
Sector: Health Care
Industry: Biotechnology

Data Updated: March 15, 2026 at 4:17 PM EDT

Ready to invest in ANEB?

Commission-free trading available. Affiliate links.

ANEB Lician Score

5% confidence

4.0/10

Neutral

ANEB has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ANEBacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ANEB Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ANEB

Dashboard

Enter a ticker to analyze